Načítá se...
CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling
CRISPR/Cas9 has revolutionized cancer mouse models. Although loss-of-function genetics by CRISPR/Cas9 is well-established, generating gain-of-function alleles in somatic cancer models is still challenging because of the low efficiency of gene knock-in. Here we developed CRISPR-based Somatic Oncogene...
Uloženo v:
| Vydáno v: | Genome Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466773/ https://ncbi.nlm.nih.gov/pubmed/30987660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-019-0627-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|